Assignee
UMC UTRECHT HOLDING BV
NL·37 granted patents·41 pending applications·127 citations·filing 2004–2025
Top patents by PatentIndex Score
78 records- 0194US10176575B2Method and system for assessing vessel obstruction based on machine learningUMC UTRECHT HOLDING BV·Filed 2018·Granted Jan 8, 2019·50 cites·26 claims
- 0290US11059909B2Engineered IgA antibodies and methods of useUMC UTRECHT HOLDING BV·Filed 2020·Granted Jul 13, 2021·4 cites·16 claims
- 0389US11091562B2Engineered IGA antibodies and methods of useUMC UTRECHT HOLDING BV·Filed 2020·Granted Aug 17, 2021·3 cites·15 claims
- 0484US11988661B2Rapid quantitative test to diagnose polycystic kidney diseaseUMC UTRECHT HOLDING BV·Filed 2021·Granted May 21, 2024·1 cites·5 claims
- 0584US10006904B2Rapid quantitative assay to measure CFTR function in a primary intestinal culture modelUMC UTRECHT HOLDING BV·Filed 2012·Granted Jun 26, 2018·6 cites·10 claims
- 0684US9891211B2Gamma 9 delta 2 T cell receptorsUMC UTRECHT HOLDING BV·Filed 2013·Granted Feb 13, 2018·8 cites·19 claims
- 0783US11035852B2Identifying drug candidates for treating polycystic kidney disease using organoids generated from primary cellsUMC UTRECHT HOLDING BV·Filed 2018·Granted Jun 15, 2021·2 cites·16 claims
- 0882US10748309B2Magnetic resonance imaging with enhanced bone visualizationUMC UTRECHT HOLDING BV·Filed 2015·Granted Aug 18, 2020·14 cites·14 claims
- 0979US10571542B2Time-domain MRIUMC UTRECHT HOLDING BV·Filed 2016·Granted Feb 25, 2020·5 cites·14 claims
- 1079US7939277B2Methods and assays for distinguishing between different forms of diseases and disorders characterized by thrombocytopenia and/or by spontaneous interaction between Von Willebrand Factor (vWF) and plateletsUMC UTRECHT HOLDING BV·Filed 2006·Granted May 10, 2011·12 cites·24 claims
- 1178US11298175B2Asymmetric balanced waveform for AC cardiac irreversible electroporationUMC UTRECHT HOLDING BV·Filed 2016·Granted Apr 12, 2022·5 cites·20 claims
- 1278US2025043010A1Method for identifying deltaT-cell (or gammaT-cell) receptor chains or parts thereof that mediate an anti-tumour or an anti-infective responseUMC UTRECHT HOLDING BV·Filed 2024·Application pending·0 cites
- 1370US11801080B2Tool system for removing prosthetic cement from a bone of a patient undergoing a joint prosthesis replacement operationUMC UTRECHT HOLDING BV·Filed 2019·Granted Oct 31, 2023·2 cites·18 claims
- 1470US10610262B2Spinal distraction systemUMC UTRECHT HOLDING BV·Filed 2017·Granted Apr 7, 2020·5 cites·17 claims
- 1569US10723789B2Immunoglobulin-like molecules directed against fibronectin-EDAUMC UTRECHT HOLDING BV·Filed 2018·Granted Jul 28, 2020·1 cites·13 claims
- 1668US11723891B2Drug combinations for use in the treatment of RAS-mutant cancerUMC UTRECHT HOLDING BV·Filed 2019·Granted Aug 15, 2023·1 cites·13 claims
- 1767US11957388B2Deformable body and combination of such deformable body and a surgical screw elementUMC UTRECHT HOLDING BV·Filed 2023·Granted Apr 16, 2024·0 cites·21 claims
- 1867US11622862B2Implant, fitting plate and method of manufacturing an implant and fitting plateUMC UTRECHT HOLDING BV·Filed 2017·Granted Apr 11, 2023·3 cites·16 claims
- 1966US12486531B2Methods for preparing nucleic acid molecules for sequencingUMC UTRECHT HOLDING BV·Filed 2023·Granted Dec 2, 2025·0 cites·11 claims
- 2066US12297274B2Method of cell therapyUMC UTRECHT HOLDING BV·Filed 2020·Granted May 13, 2025·0 cites·13 claims
- 2162US12285201B2Tool system for removing prosthetic cement from a bone of a patient undergoing a joint prosthesis replacement operationUMC UTRECHT HOLDING BV·Filed 2023·Granted Apr 29, 2025·0 cites·11 claims
- 2262US11166984B2Method for identifying δT-cell (or γT-cell) receptor chains or parts thereof that mediate an anti-tumour or an anti-infective responseUMC UTRECHT HOLDING BV·Filed 2018·Granted Nov 9, 2021·0 cites·17 claims
- 2361US12528878B2Treatment of IgE-mediated diseases with antibodies that specifically bind CD38UMC UTRECHT HOLDING BV·Filed 2023·Granted Jan 20, 2026·0 cites·20 claims
- 2461US2026042836A1Btn2a1 binding peptideUMC UTRECHT HOLDING BV·Filed 2023·Application pending·0 cites
- 2559US2025249082A1Targeted thrombolysis for treatment of microvascular thrombosisUMC UTRECHT HOLDING BV·Filed 2024·Application pending·0 cites
- 2658US2014314712A1Fusion protein comprising an interleukin 4 and interleukinUMC UTRECHT HOLDING BV·Filed 2012·Application pending·0 cites
- 2758US2023142972A1Membrane Ubiquitin ligases to target protein degradationUMC UTRECHT HOLDING BV·Filed 2021·Application pending·0 cites
- 2857US9247891B2Prediction of cardiac resynchronization therapy response based on variability of repolarizationUMC UTRECHT HOLDING BV·Filed 2014·Granted Feb 2, 2016·2 cites·23 claims
- 2957US2023184745A1Screening method for effective target - E3 ligase combinationsUMC UTRECHT HOLDING BV·Filed 2021·Application pending·0 cites
- 3057US2025332280A1Hydrogel for in-vivo release of medicationUMC UTRECHT HOLDING BV·Filed 2025·Application pending·0 cites
- 3156US11564716B2Deformable body and combination of such deformable body and a surgical screw elementUMC UTRECHT HOLDING BV·Filed 2018·Granted Jan 31, 2023·0 cites·32 claims
- 3256US2021179732A1Anti-gd2 antibody for the treatment of neuroblastomaUMC UTRECHT HOLDING BV·Filed 2020·Application pending·0 cites
- 3356US2009098563A1Diagnosis of (a risk of) disease and monitoring of therapyUMC UTRECHT HOLDING BV·Filed 2008·Application pending·0 cites
- 3454US10070855B2Surgical device for providing access to a surgical siteUMC UTRECHT HOLDING BV·Filed 2014·Granted Sep 11, 2018·1 cites·19 claims
- 3554US10011652B2Immunoglobulin-like molecules directed against fibronectin-EDAUMC UTRECHT HOLDING BV·Filed 2014·Granted Jul 3, 2018·1 cites·11 claims
- 3654US2022047856A1Hydrogel for in-vivo directional release of medicationUMC UTRECHT HOLDING BV·Filed 2019·Application pending·0 cites
- 3753US9999695B2Microsphere comprising a lanthanide metal complexUMC UTRECHT HOLDING BV·Filed 2016·Granted Jun 19, 2018·0 cites·36 claims
- 3851US12370265B2Hydrogel for in-vivo release of medicationUMC UTRECHT HOLDING BV·Filed 2020·Granted Jul 29, 2025·0 cites·20 claims
- 3949US11781170B2Methods for preparing nucleic acid molecules for sequencingUMC UTRECHT HOLDING BV·Filed 2018·Granted Oct 10, 2023·0 cites·10 claims
- 4049US2008293076A1Method to improve barrier function of cell-cell junctionsUMC UTRECHT HOLDING BV·Filed 2008·Application pending·0 cites
- 4148US12161669B2Compositions and methods for cell targeting therapiesUMC UTRECHT HOLDING BV·Filed 2018·Granted Dec 10, 2024·0 cites·8 claims
- 4248US2025009796A1Pro-apoptotic construct and use thereofUMC UTRECHT HOLDING BV·Filed 2022·Application pending·0 cites
- 4347US2007077578A1Diagnosis of (a risk of ) disease and monitoring of therapyUMC UTRECHT HOLDING BV·Filed 2006·Application pending·0 cites
- 4447US2025235213A1Anastomosis connector, a group of parts and an applicatorUMC UTRECHT HOLDING BV·Filed 2022·Application pending·0 cites
- 4546US2006241659A1Screw-device for anastomosisUMC UTRECHT HOLDING BV·Filed 2005·Application pending·0 cites
- 4646US2006253080A1Anchoring screw deviceUMC UTRECHT HOLDING BV·Filed 2005·Application pending·0 cites
- 4745US2025289904A1Single domain antibodies for the detection of plasmin-cleaved vwfUMC UTRECHT HOLDING BV·Filed 2023·Application pending·0 cites
- 4844US2025231175A1Live cell imaging platform for condensatesUMC UTRECHT HOLDING BV·Filed 2022·Application pending·0 cites
- 4944US2021023187A1Targeted Thrombolysis for Treatment of Microvascular ThrombosisUMC UTRECHT HOLDING BV·Filed 2019·Application pending·0 cites
- 5044US2018362627A1Method for preventing myocardial infarction-related complicationsUMC UTRECHT HOLDING BV·Filed 2018·Application pending·0 cites
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when UMC UTRECHT HOLDING BV files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →